HIV Lurking in Spinal Fluid Linked to Thinking Problems
TUESDAY, July 16, 2019 -- Even with long-term treatment, HIV can still be found in the cerebrospinal fluid of some people with the AIDS-causing virus, a new study reports.
And these patients are at increased risk of having thinking problems, the researchers say.
"It is difficult to target infections that lurk in the brain, and HIV is probably not an exception to the rule," said study senior author Dr. John Mellors, chief of infectious diseases at the University of Pittsburgh.
"We have our work cut out for us in the quest for an HIV cure, but knowing is half the battle, so I'm cautiously optimistic," he said in a university news release.
Researchers analyzed cerebrospinal fluid from 69 people with HIV who had been on anti-HIV therapy for an average of nine years. The study found that nearly half the participants had cells harboring HIV.
Of those who had HIV-harboring cells in their cerebrospinal fluid, 30% met criteria for thinking problems (cognitive impairment), compared with 11% of those without HIV-harboring cells in their cerebrospinal fluid.
The findings may help explain why people with well-controlled HIV can have memory and concentration problems and difficulty completing complex tasks, according to the researchers.
They also said that the results show that the brain is an important reservoir for HIV, a challenge that needs to be considered in clinical trials of potential cures.
"I don't know of a single infectious disease that is easier to treat when it's in the brain than when it's elsewhere in the body," Mellors said.
The researchers noted that the study does not prove that the presence of HIV-harboring cells in spinal fluid causes cognitive impairment. There could be several explanations for the findings, they noted.
For example, it's possible that the level of original HIV infection in the nervous system was higher in patients with HIV-harboring cells, or that the mental problems may have started early in the HIV infection, before the start of anti-HIV therapy.
However, knowing about a possible link between even well-controlled HIV infection and thinking issues can help doctors track patients who may need additional monitoring, Mellors said.
The study was published July 15 in the Journal of Clinical Investigation.
© 2020 HealthDay. All rights reserved.
Posted: July 2019
Read this next
THURSDAY, Sept. 10, 2020 -- The daily drug regimen known as PrEP is a nearly foolproof way to prevent HIV infection. But a new study suggests that many high-risk Americans may be...
THURSDAY, Aug. 27, 2020 -- The daily use of antiretroviral meds to help prevent HIV infection has been around for a few years now -- it's called pre-exposure prophylaxis, or...
WEDNESDAY, Aug. 26, 2020 -- HIV researchers have long known that in rare cases, patients can naturally suppress the virus without taking medication. Now, a new study offers...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
- Monthly Update Archive
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.